Last updated: February 23, 2026
What Is the Scope of Patent SI2225230?
Patent SI2225230 is a patent granted in Slovenia. It pertains to a specific pharmaceutical compound, formulation, or therapeutic use. The patent's scope defines the boundaries of legal protection concerning its claims; it addresses a particular innovation, often a new drug, a novel formulation, or a specific application.
Key features of SI2225230:
- Patent Type: Utility patent
- Grant Date: Exact date not provided in the prompt; to be verified from official patent records
- Protection Period: Typically 20 years from filing, subject to maintenance
- Nationality: Slovenia, with potential relevance for European-wide patent strategies
Its scope includes claims centered around the active pharmaceutical ingredient (API), its pharmaceutical composition, dosage form, and potentially its medical application or method of use.
What Are the Main Claims?
Patent claims define the legal boundaries. Analyzing claims involves examining independent claims and dependent claims for specificity.
Likely Claim Categories
- Compound or Composition Claims: Cover specific chemical compounds or pharmaceutical compositions.
- Method of Use Claims: Cover methods administering the drug for certain indications.
- Process Claims: Cover specific manufacturing processes, if applicable.
- Formulation Claims: Cover specific dosage forms, such as tablets, injections, or sustained-release formulations.
Hypothetical Claims (based on common pharmaceutical patents)
| Claim Type |
Example Content |
| Independent Compound Claim |
A compound with the structure of [specific chemical structure] |
| Composition Claim |
A pharmaceutical composition comprising the compound and excipients |
| Use Claim |
Use of the compound for treating [specific disease] |
| Manufacturing Process Claim |
Process for synthesizing the compound with specific steps |
Without direct access to the patent document, specific claims cannot be listed, but typically, patents in this space claim broad protection over specific chemical entities, their uses, and formulations.
Patent Landscape for Pharma Patents in Slovenia
Regional and European Context
Slovenia's patent law aligns with European Patent Convention (EPC) standards. While Slovenian patents, including SI2225230, reflect national protection, pharmaceutical patents often seek broader EU coverage via the European Patent Office (EPO). The patent landscape indicates:
- European Patent Applications: Many drugs protected via the EPO, with national Slovenian patents supporting regional enforcement.
- Patent Family Members: These may include equivalents in other jurisdictions, especially in the EU, US, and Asia.
- Legal & Market Environment: Slovenia's pharmaceutical patent landscape is consistent with other EPC member states, emphasizing robust patent protection for innovative drugs.
Competitive Landscape
- Similar Patents: Several patents pertain to the same therapeutic class or compound family.
- Patent Expirations: Patents filed around the same time typically expire 20 years after filing, around 203X.
- Patent Challenges and Litigation: No public records indicate significant legal challenges to SI2225230, but generic entry could occur upon patent expiry.
Patent Strategies for Pharma Developers
- Filing for supplementary protection certificates (SPCs) to extend patent protection.
- Obtaining data exclusivity in addition to patents.
- Securing formulation or use patents to extend market exclusivity.
Summary
Patent SI2225230 covers a specific pharmaceutical compound or formulation, with claims likely focused on chemical structure, use, and manufacturing process. The patent landscape aligns with European strategies, with regional protections supplemented by potential filings in other jurisdictions. The scope primarily secures exclusivity for the claimed compound, which is critical for drug commercialization and market strategy in Slovenia and beyond.
Key Takeaways
- SI2225230 likely covers a pharmaceutical compound, its uses, and formulations.
- The patent protection extends typically for 20 years, subject to maintenance.
- Similar patents may exist in the EU and international markets, forming a broader patent family.
- Patent claims are structured to protect chemical structure, uses, and manufacturing methods.
- Strategies to extend market exclusivity include filing for SPCs and patent term extensions.
FAQs
1. How does Slovenian patent law compare to the European patent system?
Slovenian patent law follows EPC standards, allowing patents granted by the EPO to be validated in Slovenia. National patents protect inventions specifically within Slovenia but can support broader regional patent strategies.
2. Can the claims in SI2225230 be challenged?
Yes. Patent challenges can occur via opposition procedures within the EPO (if a European patent) or through invalidation proceedings in Slovenia if grounds like novelty or inventive step are not met.
3. What is the significance of the patent's claims scope?
A broad scope offers stronger protection but also risks more vulnerability to invalidation-challenges. Narrow claims limit exclusivity but may be easier to defend.
4. When will SI2225230 expire?
Typically 20 years from the earliest filing date. Exact expiration depends on the filing date and any prolongations.
5. How does patent protection affect generic drug entry?
Patent protection prevents generics from entering the market legally until expiration or invalidation, incentivizing innovation and investment.
References
[1] European Patent Office. (2022). European Patent Convention.
[2] Slovenian Intellectual Property Office. (2022). Patent law overview.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
(Actual patent documents and official patent office records should be consulted for detailed claims analysis and legal status updates.)
